ImageneBio Inc
IMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $776 | $741 | $950 |
| - Cash | $103 | $58 | $37 | $39 |
| + Debt | $9 | $6 | $7 | $8 |
| Enterprise Value | – | $723 | $711 | $918 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$4 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$25 | -$8 | -$9 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$25 | -$3 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.005 | -0.057 | -0.18 | -0.19 |
| % Growth | -5,144.7% | 68.2% | 5.3% | – |
| Operating Cash Flow | -$27 | -$3 | -$11 | -$6 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$27 | -$3 | -$11 | -$6 |